Replies to post #184488 on Biotech Values

[jq1234]

How's that for the perfect timing :-)? Per Twitter, MRK can't walk away from this deal based on this news alone:

.@MarkSchoenebaum says: According to the merger document, it is appears that $MRK cannot walk away from this deal for today's news only.

— Ian Estepan (@ianestepan) December 8, 2014

CBST PR: "Our transaction announced today with Merck is unaffected, and we will move forward toward its completion in the first quarter of 2015.”

http://finance.yahoo.com/news/cubist-comments-cubicin-patent-litigation-235200083.html